Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Genetic marker rs12558842 strongly linked to male hair loss.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Changes in keratin affect skin health and can lead to skin disorders like blistering diseases and psoriasis.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Using longer PEG chains helps nanoparticles penetrate hair follicles better, improving drug delivery for conditions like alopecia.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.